GlassScriptPhysician profile
Sam Nia
NPI 1407121445
$79,647.28
in general payments reported to CMS, 2019-2025
11 companies · $3,741 in 2025
The $3,741 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $402 · 2021: $3,659 · 2022: $8,010 · 2023: $38K · 2024: $26K · 2025: $3,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $17K · Travel and Lodging: $8,733 · Food and Beverage: $4,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,350.00 |
| Consulting Fee | $17,212.50 |
| Travel and Lodging | $8,733.22 |
| Food and Beverage | $4,280.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $72,675.34 | 2021-2025 | Stimrouter Implantable Kit, Stimrouter Implantable Kit, None |
| Nalu Medical, INC. | $3,147.92 | 2021-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $1,459.12 | 2020-2025 | Sprint Pns System |
| Bioness INC | $834.52 | 2020-2021 | |
| Boston Scientific Corporation | $400.68 | 2021-2024 | Intracept |
| Relievant Medsystems, INC. | $340.39 | 2023 | Intracept |
| Epimed International, INC | $271.76 | 2024 | Needles and Catheters |
| Nevro Corp. | $190.83 | 2021-2022 | |
| Painteq LLC | $139.40 | 2024 | Painteq |
| Medtronic, INC. | $117.44 | 2021-2025 | Inceptiv |
| Heron Therapeutics, INC. | $69.88 | 2025 | Aponvie, Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Nia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.